DAIVOBET Gel Ref.[50669] Active ingredients: Betamethasone Calcipotriol

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2019  Publisher: LEO Pharma A/S, Industriparken 55, DK-2750 Ballerup, Denmark

Product name and form

Dovobet 50 microgram/g + 0.5 mg/g gel.

Pharmaceutical Form

Gel.

An almost clear, colourless to slightly off-white gel.

Qualitative and quantitative composition

One gram of gel contains 50 micrograms of calcipotriol (as monohydrate) and 0.5 mg of betamethasone (as dipropionate).

Excipient with known effect: Butylhydroxytoluene (E321) 160 micrograms/g gel.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Betamethasone

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.

Calcipotriol

Calcipotriol is a derivative of vitamin D for topical use on psoriasis. It probably works by suppressing keratinization. Advantage of substance or absence of odor and non-coloring of clothing.

List of Excipients

Paraffin, liquid
Polyoxypropylene stearyl ether
Castor oil, hydrogenated
Butylhydroxytoluene (E321)
All-rac-α-tocopherol

Pack sizes and marketing

Bottles: High-density polyethylene bottles with low-density polyethylene nozzle and a high-density polyethylene screw cap. The bottles are placed in cartons.

Pack sizes: 15 g, 30 g, 60 g, 80 g, 2 × 60 g, 2 × 80 g and 3 × 60 g.

Applicator: The Applicator consists of a polypropylene cartridge (with a high-density polyethylene plunger and screw cap), an applicator head (polypropylene outer casing, polyoxymethylene lever and thermoplastic elastomer nozzle) and polypropylene cover. The cartridge, applicator head and cover are assembled prior to use. The cartridge(s), applicator head(s) and cover(s) are placed in a carton.

Pack sizes: 60 g (equivalent to 68 ml) and 2 × 60 g (equivalent to 2 × 68 ml)

Not all pack sizes may be marketed.

Marketing authorization holder

LEO Pharma A/S, Industriparken 55, DK-2750 Ballerup, Denmark

Marketing authorization dates and numbers

PL 05293/0005

Date of first authorisation: 25 September 2008

Date of latest renewal: 1 October 2015

Drugs

Drug Countries
DAIVOBET Austria, Australia, Brazil, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Israel, Lithuania, Malta, Mexico, Nigeria, New Zealand, Poland, Romania, Singapore, Tunisia

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.